International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
- 6 July 2010
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Pharmacological Reviews
- Vol. 62 (3), 343-380
- https://doi.org/10.1124/pr.110.002832
Abstract
The hormone melatonin (5-methoxy-N-acetyltryptamine) is synthesized primarily in the pineal gland and retina, and in several peripheral tissues and organs. In the circulation, the concentration of melatonin follows a circadian rhythm, with high levels at night providing timing cues to target tissues endowed with melatonin receptors. Melatonin receptors receive and translate melatonin's message to influence daily and seasonal rhythms of physiology and behavior. The melatonin message is translated through activation of two G protein-coupled receptors, MT1 and MT2, that are potential therapeutic targets in disorders ranging from insomnia and circadian sleep disorders to depression, cardiovascular diseases, and cancer. This review summarizes the steps taken since melatonin's discovery by Aaron Lerner in 1958 to functionally characterize, clone, and localize receptors in mammalian tissues. The pharmacological and molecular properties of the receptors are described as well as current efforts to discover and develop ligands for treatment of a number of illnesses, including sleep disorders, depression, and cancer.Keywords
This publication has 377 references indexed in Scilit:
- Ligand binding to the human MT2 melatonin receptor: The role of residues in transmembrane domains 3, 6, and 7Biochemical and Biophysical Research Communications, 2005
- The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissuesLife Sciences, 2005
- Expression of membrane and nuclear melatonin receptors in mouse peripheral organsLife Sciences, 2004
- Mutagenesis of Human Mel1aMelatonin Receptor Expressed in Yeast Reveals Domains Important for Receptor FunctionBiochemical and Biophysical Research Communications, 1998
- The Roles of Valine 208 and Histidine 211 in Ligand Binding and Receptor Function of the Ovine Mel1aβMelatonin ReceptorBiochemical and Biophysical Research Communications, 1997
- Melatonin: Binding site characteristics and biochemical and cellular responsesNeurochemistry International, 1994
- Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cellsLife Sciences, 1993
- Intrahelical hydrogen bonding of serine, threonine and cysteine residues within α-helices and its relevance to membrane-bound proteinsJournal of Molecular Biology, 1984
- Measurement of 6-hydroxymelatonin in human urine and its diurnal variationsLife Sciences, 1980
- Structure-activity relationships of melatonin and related indoleaminesLife Sciences, 1975